{
  "trial_id": "NCT03207945",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.",
      "label": "met"
    },
    {
      "criterion": "Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.",
      "label": "met"
    },
    {
      "criterion": "Males and females equal or greater than 40 years of age.",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Subjects who are investigational site staff members directly involved in the conduct of the trial and their family members, site staff members otherwise supervised by the Investigator, or subjects who are Regeneron employees.",
      "label": "unknown"
    },
    {
      "criterion": "Participation in other studies involving small molecule investigational drug(s).",
      "label": "unknown"
    }
  ],
  "notes": "The patient has type 1 diabetes and cardiomyopathy, but no history of cardiovascular or cerebrovascular events. He is willing to comply with study procedures.",
  "_meta": {
    "topic_id": "65",
    "trial_id": "NCT03207945",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}